This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
HYI Monoclonal Antibody (2A2)
catalog :
MA5-24554
quantity :
100 ug
price :
US 474.00
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
2A2
reactivity :
human
application :
immunohistochemistry, immunohistochemistry - paraffin section
product information
Product Type :
Antibody
Product Name :
HYI Monoclonal Antibody (2A2)
Catalog # :
MA5-24554
Quantity :
100 ug
Price :
US 474.00
Clonality :
Monoclonal
Purity :
protein A
Host :
Mouse
Reactivity :
Human
Applications :
ELISA: 0.1 ng/mL, Immunohistochemistry (Paraffin): Assay-Dependent
Species :
Human
Clone :
2A2
Isotype :
IgG1, kappa
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
Catalyzes the reversible isomerization between hydroxypyruvate and 2-hydroxy-3-oxopropanoate (also termed tartronate semialdehyde).
Immunogen :
HYI (AAH06140, 1 a.a. ~ 217 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Format :
Liquid
Applications w/Dilutions :
ELISA: 0.1 ng/mL, Immunohistochemistry (Paraffin): Assay-Dependent
Aliases :
2700033B16Rik; 6430559E15Rik; endothelial cell apoptosis protein E-CE1; HT036; hydroxypyruvate isomerase; hydroxypyruvate isomerase (putative); hydroxypyruvate isomerase homolog; hydroxypyruvate isomerase homolog (E. coli); HYI; Putative hydroxypyruvate isomerase; RGD1561416; SB156
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments